Article Figures & Data
Tables
<75 Years of Age ≥75 Years of Age Patients 1190 (53%) 1064 (47%) Mean age 59 ± 11 84 ± 6 Sex Male 684 (58%) 410 (39%) Female 506 (42%)a 654 (61%)a LDL 96 ± 42b 86 ± 37b Warfarin use 113 (9.5%)a 191 (18%)a Statin use 453 (38%) 442 (41%) Diabetes 383 (32%)a 294 (28%)a Hypertension 848 (71%)a 902 (85%)a Heart disease 410 (34%)a 483 (45%)a Atrial fibrillation 171 (14%)a 452 (42%)a Arriving to hospital within 8 hours 468 (39%) 457 (43%) NIHSS admission score Median 4b 6b IQR 2–11 2–16 Prestroke mBI Median 20b 19b IQR 20–20 18–20 -
↵a P < .05, χ2 test.
-
<75 Years of Age ≥75 Years of Age Patients 70 (65%) 37 (35%) Mean age 60 ± 13 80 ± 4 Sex Male 40 (57%) 14 (38%) Female 30 (43%) 23 (62%) LDL 83 ± 37a 65 ± 29a INR value 1.1 ± .25 1.2 ± .37 Warfarin use 9 (12%) 10 (24%) Statin use 19 (44%) 18 (56%) Diabetes 15 (19%) 13 (32%) Hypertension 51 (65%)a 34 (82%)a Heart disease 29 (37%) 20 (49%) Atrial fibrillation 23 (30%)a 21 (51%)a Admission NIHSS score Median 17.5 18 IQR 12.75–21 16–22.5 Prestroke mBI Median 20a 19a IQR 20–20 19–20 -
↵a P < .05, χ2 test.
-
<75 Years of Age ≥75 Years of Age Total 70/1190 (5.9%)a 37/1064 (3.5%)a Male 40/684 (5.8%) 14/410 (3.4%) Female 30/506 (5.9%) 23/654 (3.5%) Treatment regimen IA only 18 (26%) 8 (22%) IV and IA 16 (23%) 12 (32%) IA and device 11 (16%) 5 (14%) Device only 21 (30%) 12 (32%) IV, IA, and device 4 (6%) 0 Time to intervention 141 ± 92 153 ± 87 Duration of intervention 204 ± 69a 172 ± 55a Recanalization rate 68% 79% -
↵a P < .05, χ2 test.
-
- Table 4:
Short- and long-term outcomes in patients with AIS receiving endovascular treatment
<75 Years of Age (n = 70) ≥75 Years of Age (n = 37) Decrease in NIHSS score ≥ 4 70% 82% Symptomatic ICH 9%a 24%a In-hospital mortality 26%a 46%a mBI ≥ 15 at 3 months 51%a 28%a mBI ≥ 15 at 1 year 52%a 22%a -
↵a P < .05, χ2 test.
-